Liquid biopsies and plasma DNA: paving the way for personalized medicine in metastatic castration-resistant prostate cancer.

about

Liquid biopsies and plasma DNA: paving the way for personalized medicine in metastatic castration-resistant prostate cancer.

Item

http://www.wikidata.org/entity/Q53741855

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@en

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@nl

type

Item

label

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@en

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@nl

prefLabel

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@en

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@nl

P1476

Liquid biopsies and plasma DNA ...... ion-resistant prostate cancer.

@en

P2093

R J van Soest

http://www.w3.org/2001/XMLSchema#string

P2860

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.

The Natural History and Outcome Predictors of Metastatic Castration-resistant Prostate Cancer.

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer.

P304

1408-1409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/ANNONC/MDX208

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28459972

http://www.w3.org/2001/XMLSchema#string

P921

biopsy